Pomalidomide and HDAC Inhibitors in Multiple Myeloma | OncLive
onclive.com
Pomalidomide and HDAC Inhibitors in Multiple Myeloma | OncLive
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Jan 12, 2015
Related Products
Pomalyst Pomalidomide
Pomalidomide 4 mg Capsules
10 Mg Pomalidomide
#Pomalidomide Uses
How God Uses Ordinary People To Do The Unexpected
How God Uses Ordinary People To Do The Unexpected
deepspirituality.comMay 18, 2017
Oral medication improves quality of life for patients with rare vascular disorder
Oral medication improves quality of life for patients with rare vascular disorder
clevelandclinic.orgSep 23, 2024
Top videos
Pomalidomide and Carfilzomib in Refractory Multiple Myeloma | OncLive
Pomalidomide and Carfilzomib in Refractory Multiple Myeloma | OncLive
onclive.com
Jul 17, 2015
Pomalidomide and Carfilzomib in Multiple Myeloma | OncLive
Pomalidomide and Carfilzomib in Multiple Myeloma | OncLive
onclive.com
Jul 10, 2014
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma The immunostimulatory monoclonal antibody elotuzumab plus lenalidomide and dexamethasone has been shown to be effective in patients with relapsed or refractory multiple myeloma. The immunomodulatory agent pomalidomide plus dexamethasone has been shown to be effective in patients with multiple myeloma that is refractory to lenalidomide and a proteasome inhibitor. Read more: https://www.nejm.org/doi/full/10.1056/NEJMoa1805762?quer
1:41
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma The immunostimulatory monoclonal antibody elotuzumab plus lenalidomide and dexamethasone has been shown to be effective in patients with relapsed or refractory multiple myeloma. The immunomodulatory agent pomalidomide plus dexamethasone has been shown to be effective in patients with multiple myeloma that is refractory to lenalidomide and a proteasome inhibitor. Read more: https://www.nejm.org/doi/full/10.1056/NEJMoa1805762?quer
FacebookBlood and Hematology
1.1K viewsNov 8, 2018
Pomalidomide Side Effects
For patients with hereditary hemorrhagic telangiectasia, no approved therapies exist. The efficacy and safety of pomalidomide, a thalidomide derivative, in treating HHT is unknown. Research findings are summarized in a new Quick Take video. https://nej.md/3MUk9VW | The New England Journal of Medicine
2:08
For patients with hereditary hemorrhagic telangiectasia, no approved therapies exist. The efficacy and safety of pomalidomide, a thalidomide derivative, in treating HHT is unknown. Research findings are summarized in a new Quick Take video. https://nej.md/3MUk9VW | The New England Journal of Medicine
FacebookThe New England Journal of
1.2K viewsSep 23, 2024
Pomalidomide Capsule: Uses, Dosage, Mechanism, Side Effects, and Important Advice | MediInsights
4:14
Pomalidomide Capsule: Uses, Dosage, Mechanism, Side Effects, and Important Advice | MediInsights
YouTubeMediInsights
215 viewsJun 30, 2024
What Women Need to Know About Lexapro and Its Potential Side Effects
What Women Need to Know About Lexapro and Its Potential Side Effects
womenshealthmag.com
1 year ago
Pomalidomide and Carfilzomib in Refractory Multiple Myeloma | OncLive
Pomalidomide and Carfilzomib in Refractory Multiple Myeloma | Onc…
Jul 17, 2015
onclive.com
Pomalidomide and Carfilzomib in Multiple Myeloma | OncLive
Pomalidomide and Carfilzomib in Multiple Myeloma | OncLive
Jul 10, 2014
onclive.com
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma The immunostimulatory monoclonal antibody elotuzumab plus lenalidomide and dexamethasone has been shown to be effective in patients with relapsed or refractory multiple myeloma. The immunomodulatory agent pomalidomide plus dexamethasone has been shown to be effective in patients with multiple myeloma that is refractory to lenalidomide and a proteasome inhibitor. Read more: https://www.nejm.org/doi/full/10.1056/NEJMoa1805762?quer
1:41
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myelo…
1.1K viewsNov 8, 2018
FacebookBlood and Hematology
Testing The Combination of Talquetamab, Daratumab, and Pomalidomide To Treat Multiple Myeloma
4:15
Testing The Combination of Talquetamab, Daratumab, and Po…
179 viewsJan 21, 2025
YouTubeCheckRare
Dr. Chari on PVd for Relapsed Patients With Multiple Myeloma | OncLive
Dr. Chari on PVd for Relapsed Patients With Multiple Myeloma | …
Dec 18, 2018
onclive.com
Pomalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma
2:32
Pomalidomide and low-dose dexamethasone for relapsed or ref…
252 viewsJun 13, 2017
YouTubeecancer
Pomalidomide in Refractory Multiple Myeloma
10:27
Pomalidomide in Refractory Multiple Myeloma
1.5K viewsAug 15, 2014
YouTubeOncLive
1:08
Dr. Berenson on Pomalidomide in Relapsed/Refractory Multiple Myel…
179 viewsFeb 4, 2013
YouTubeTargeted Oncology
3:57
Belantamab plus pomalidomide and dexamethasone as a maintenance …
85 views6 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:45
Real-world safety & efficacy of isatuximab-pomalidomide-dexame…
94 viewsOct 6, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:55
Updated DREAMM-8 Data: Belantamab-Pomalidomide-Dex in …
481 views9 months ago
YouTubeHealthTree University for Multiple Myeloma
2:00
Updated results from DREAMM-8: belamaf plus pomalidomide and d…
92 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Pomalyst (pomalidomid) bivirkninger, interaktioner, anvend…
Aug 24, 2019
oldmedic.com
1:07
Long-term follow-up of belantamab mafodotin plus pomalidomide an…
36 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
14:12
Results From the Randomized Phase 3 DREAMM-8 Study of Bela…
Jul 9, 2024
onclive.com
3:03
In this week’s video, Dr. Brian G.M. Durie explains the recent FDA app…
607 viewsNov 19, 2018
FacebookInternational Myeloma Foundation
2:50
CANOVA: venetoclax plus dexamethasone vs pomalidomide …
183 viewsNov 9, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:35
Isatuximab phase 3 study in patients with relapsed and refractory multi…
1.7K viewsNov 15, 2019
YouTubeThe Lancet
1:39
Expanding on Data Surrounding Isatuximab Plus Pomalidomide/De…
61 viewsSep 15, 2019
YouTubeTargeted Oncology
1:22
Phase II study of isatuximab, pomalidomide and dexamethason…
84 viewsDec 8, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:06
ASH12: New Myeloma Drug Works Better with Low-Dose Dexamethas…
626 viewsDec 11, 2012
YouTubeMDedge: news and insights for busy physicians
2:34
Phase II dose optimization study of inobrodib with pomalidomide and …
48 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Novel PROTACs Targeting Cereblon | JoVE Journal
13.5K viewsMay 15, 2019
jove.com
6:14
Selinexor Pom Dex (SPd) Combo Shows Promise: New Treatment O…
420 viewsJan 28, 2025
YouTubeInternational Myeloma Foundation
12:32
Subcutaneous vs IV isatuximab + pomalidomide/dexamethasone in …
225 views8 months ago
YouTubeInternational Myeloma Foundation
2:08
For patients with hereditary hemorrhagic telangiectasia, no ap…
1.2K viewsSep 23, 2024
FacebookThe New England Journal of Medicine
Oral medication improves quality of life for patients with rare vascular …
Sep 23, 2024
clevelandclinic.org
8:29
ASCO 2024 - LBA105: The DREAMM-8 study
147 viewsJun 4, 2024
YouTubeOncoletter
4:14
Pomalidomide Capsule: Uses, Dosage, Mechanism, Side Effects, …
215 viewsJun 30, 2024
YouTubeMediInsights
See more videos
Static thumbnail place holder